Cenerx Biopharma, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2005-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.cenerx.com
Clinical Trials
5
Active:0
Completed:4
Trial Phases
2 Phases
Phase 1:3
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (60.0%)Phase 2
2 (40.0%)Oral Tyramine Pressor Response Study of CX157 Tablets in Healthy Male Volunteers
- First Posted Date
- 2012-07-04
- Last Posted Date
- 2012-07-04
- Lead Sponsor
- CeNeRx BioPharma Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT01633437
- Locations
- 🇺🇸
Comprehensive Phase One, Miramar, Florida, United States
Pharmacokinetic Study of CXB909 in Healthy Male Subjects
- First Posted Date
- 2012-01-09
- Last Posted Date
- 2012-01-09
- Lead Sponsor
- CeNeRx BioPharma Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT01505907
Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression
Phase 2
Completed
- Conditions
- Treatment Resistant Depression
- Interventions
- Drug: Placebo
- First Posted Date
- 2010-11-24
- Last Posted Date
- 2012-07-10
- Lead Sponsor
- CeNeRx BioPharma Inc.
- Target Recruit Count
- 360
- Registration Number
- NCT01246908
- Locations
- 🇺🇸
Synergy Escondido, Escondido, California, United States
🇺🇸Synergy Clinical Research Center, National City, California, United States
🇺🇸Excell Research, Oceanside, California, United States
Examining the Effects of CXB722 in Neuroendocrine Stress Response in Healthy Males
- First Posted Date
- 2008-12-25
- Last Posted Date
- 2009-01-13
- Lead Sponsor
- CeNeRx BioPharma Inc.
- Target Recruit Count
- 23
- Registration Number
- NCT00814931
- Locations
- 🇺🇸
University of South Florida, Tampa, Florida, United States
A Study of CX157 (TriRima) for the Treatment of Depression
- First Posted Date
- 2008-08-22
- Last Posted Date
- 2012-06-27
- Lead Sponsor
- CeNeRx BioPharma Inc.
- Target Recruit Count
- 285
- Registration Number
- NCT00739908
- Locations
- 🇺🇸
Birmingham Research Group, Birmingham, Alabama, United States
🇺🇸Southwestern Research, Inc., Beverly Hills, California, United States
🇺🇸The George Washington University, Washington, District of Columbia, United States
News
No news found